Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023;147(8):e93–621.

Article  PubMed  Google Scholar 

Blagov AV, Markin AM, Bogatyreva AI, et al. The Role of Macrophages in the Pathogenesis of Atherosclerosis. Cells. 2023;12(4):522.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen R, McVey DG, Shen D, et al. Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis. J Am Heart Assoc. 2023;12(20):e031121.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Razi S, YaghmoorianKhojini J, Kargarijam F, et al. Macrophage efferocytosis in health and disease. Cell Biochem Funct. 2023;41(2):152–65.

Article  CAS  PubMed  Google Scholar 

Rochette L, Dogon G, Rigal E, et al. Interplay between efferocytosis and atherosclerosis. Arch Cardiovasc Dis. 2023;116(10):474–84.

Article  PubMed  Google Scholar 

Cai B, Thorp EB, Doran AC, et al. Mertk cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc Natl Acad Sci U S A. 2016;113:6526–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kojima Y, Volkmer JP, McKenna K, et al. Cd47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hou P, Fang J, Liu Z, et al. Macrophage polarization and metabolism in atherosclerosis. Cell Death Dis. 2023;14(10):691.

Article  PubMed  PubMed Central  Google Scholar 

Tizaoui K, Yang JW, Lee KH, et al. The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review. Int J Biol Sci. 2022;18(9):3731–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Michelsen AE, Rathcke CN, Skjelland M, et al. Increased ykl-40 expression in patients with carotid atherosclerosis. Atherosclerosis. 2010;211:589–95.

Article  CAS  PubMed  Google Scholar 

Schroder J, Jakobsen JC, Winkel P, et al. Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease. J Am Heart Assoc. 2020;9(5):e014634.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao G, Sun J, Zhong T, et al. Association of serum YKL-40 change with prognosis in acute ischemic stroke patients complicated with diabetes mellitus. Biomark Med. 2023;17(5):253–63.

Article  CAS  PubMed  Google Scholar 

Huan W, Yandong L, Chao W, et al. YKL-40 Aggravates Early-Stage Atherosclerosis by Inhibiting Macrophage Apoptosis in an Aven-dependent Way. Front Cell Dev Biol. 2021;9:752773.

Article  PubMed  PubMed Central  Google Scholar 

Mohd AB, Alabdallat Y, Mohd OB, et al. Medical and Surgical Management of Symptomatic and Asymptomatic Carotid Artery Stenosis: A Comprehensive Literature Review. Cureus. 2023;15(8):e43263.

PubMed  PubMed Central  Google Scholar 

Markus B, Grote K, Worsch M, P et al. Differential expression of micrornas in endarterectomy specimens taken from patients with asymptomatic and symptomatic carotid plaques. PloS one. 2016;11:e0161632

Noonan J, Bobik A, Peter K. The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture. Br J Pharmacol. 2022;179(5):979–97.

Article  CAS  PubMed  Google Scholar 

Mizoguchi E. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology. 2006;130:398–411.

Article  CAS  PubMed  Google Scholar 

Homorodean C, Leucuta DC, Ober M, et al. Intravascular ultrasound insights into the unstable features of the coronary atherosclerotic plaques: A systematic review and meta-analysis. Eur J Clin Invest. 2022;52(1):e13671.

Article  PubMed  Google Scholar 

Wang Z, Tao T, Tao Y. ChIP and ChIRP Assays in Ferroptosis. Methods Mol Biol. 2023;2712:19–27.

Article  CAS  PubMed  Google Scholar 

Liu K, Jin M, Ye S, Yan S. CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53. J Clin Lab Anal. 2020;34(1):e23026.

Article  PubMed  Google Scholar 

Yu R, Liu X, Deng X, et al. Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis. Front Immunol. 2023;14:1211790.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ochman B, Mielcarska S, Kula A, et al. Do Elevated YKL-40 Levels Drive the Immunosuppressive Tumor Microenvironment in Colorectal Cancer? Assessment of the Association of the Expression of YKL-40, MMP-8, IL17A, and PD-L1 with Coexisting Type 2 Diabetes, Obesity, and Active Smoking. Curr Issues Mol Biol. 2023;45(4):2781–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu T, Zheng X, Wang A, et al. Association of CHI3L1 gene variants with YKL-40 levels and hypertension incidence: A population-based nested case-control study in China. J Cell Mol Med. 2021;25(2):919–24.

Article  CAS  PubMed  Google Scholar 

Song M, Zhang G, Shi H, et al. Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events. Front Cardiovasc Med. 2023;10:1242339.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwon Y, Kim JH, Ha EK, Jee HM, Baek HS, Han MY, Jeong SJ. Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children. Mediators Inflamm. 2020;26(2020):8713908.

Google Scholar 

Wang Y, Wang Q, Xu D. New insights into macrophage subsets in atherosclerosis. J Mol Med (Berl). 2022;100(9):1239–51.

Article  CAS  PubMed  Google Scholar 

Gong Z, Xing S, Zheng F, Xing Q. Increased expression of chitinase 3-like 1 in aorta of patients with atherosclerosis and suppression of atherosclerosis in apolipoprotein e-knockout mice by chitinase 3-like 1 gene silencing. Mediators Inflamm. 2014;2014:905463.

Article  PubMed  PubMed Central  Google Scholar 

Jung TW, Park HS, Choi GH, Kim D, Jeong JH, Lee T. Chitinase-3-like protein 1 ameliorates atherosclerotic responses via ppardelta-mediated suppression of inflammation and er stress. J Cell Biochem. 2018;119:6795–805.

Article  CAS  PubMed  Google Scholar 

Wang M, McGraw KR, Monticone RE. Milk Fat Globule Epidermal Growth Factor VIII Fragment Medin in Age-Associated Arterial Adverse Remodeling and Arterial Disease. Cells. 2023;12(2):253.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Viola JR, Lemnitzer P, Paulin N, et al. Deletion of mfge8 inhibits neointima formation upon arterial damage. Thromb Haemost. 2018;118:1340–2.

Article  PubMed  Google Scholar 

Li K, Chen G, Luo H, et al. MRP8/14 mediates macrophage efferocytosis through RAGE and Gas6/MFG-E8, and induces polarization via TLR4-dependent pathway. J Cell Physiol. 2021;236(2):1375–90.

Article  CAS  PubMed  Google Scholar